MAHBUB, A.A., LE MAITRE, C.L., HAYWOOD-SMALL, S.L., CROSS, N.A. and JORDAN-MAHY, N. (2015). Glutathione is key to the synergistic enhancement of doxorubicin and etoposide by polyphenols in leukaemia cell lines. Cell Death and Disease, 6, e2028. [Article]
Documents
11343:34116
PDF
Mahbub et al - Glutathione is key to the synergistic enhancements of doxorubin.pdf - Published Version
Available under License Creative Commons Attribution.
Mahbub et al - Glutathione is key to the synergistic enhancements of doxorubin.pdf - Published Version
Available under License Creative Commons Attribution.
Download (708kB) | Preview
11343:34128
PDF (Acceptance e-mail)
Jordan-Mahy - 11343.pdf
Restricted to Repository staff only
Jordan-Mahy - 11343.pdf
Restricted to Repository staff only
Download (177kB)
Abstract
Recently published in Nature: Cell Death and Discovery,
Mahbub et al.1 have demonstrated that polyphenols can
synergistically enhance the action of the topoisomerase II
inhibitors: doxorubicin and etoposide in leukaemia cells. A
reduction of glutathione (GSH) was strongly associated with
sensitising cells to the pro-apoptotic effects of polyphenols when used in combination with doxorubicin or etoposide. Importantly, when polyphenols and topoisomerase II inhibitors were combined, it was possible to induce a
synergistic decrease in cell proliferation (measured as ATP
levels), cell-cycle arrest and induction of apoptosis in
leukaemia cell lines.
More Information
Statistics
Downloads
Downloads per month over past year
Metrics
Altmetric Badge
Dimensions Badge
Share
Actions (login required)
![]() |
View Item |